TriSalus Life Sciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $7,349 | $7,364 | $6,457 | $5,721 |
Gross Profit | 6,345 | 6,452 | 5,486 | 5,139 |
EBITDA | -1,010 | -3,177 | -13,025 | -35,303 |
EBIT | -1,179 | -3,371 | -13,213 | -35,505 |
Net Income | -2,399 | -4,332 | -13,219 | -35,509 |
Net Change In Cash | 7,349 | 7,364 | 6,457 | 5,721 |
Free Cash Flow | -11,016 | -13,482 | -10,933 | -9,549 |
Cash | 11,288 | 16,481 | 3,970 | 11,777 |
Basic Shares | 26,501 | 23,903 | 23,323 | 9,395 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $18,511 | $12,398 | $8,401 |
Gross Profit | 15,906 | 10,140 | 7,208 |
EBITDA | -58,298 | -46,763 | -23,568 |
EBIT | -59,000 | -47,177 | -24,032 |
Net Income | -59,038 | -47,187 | -28,845 |
Net Change In Cash | 18,511 | 12,398 | 8,401 |
Free Cash Flow | -51,166 | -33,099 | -23,955 |
Cash | 11,777 | 9,414 | 30,301 |
Basic Shares | 9,395 | 29,608 | 31,250 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.39 |
2024-06-30 | -$0.21 |
2024-03-31 | -$0.60 |
2023-12-31 | -$1.56 |
